Fairmount Funds Management LLC Annexon, Inc. Transaction History

Fairmount Funds Management LLC

  • $504 Million
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 09, 2022
BUY
$3.75 - $6.63 $1.75 Million - $3.09 Million
465,963 Added 16.11%
3,358,563 $20.8 Million
Q2 2022

Aug 15, 2022
BUY
$2.11 - $4.06 $3.47 Million - $6.67 Million
1,643,457 Added 131.57%
2,892,600 $10.9 Million
Q1 2022

May 16, 2022
BUY
$2.73 - $11.94 $3.41 Million - $14.9 Million
1,249,143 New
1,249,143 $3.41 Million

Others Institutions Holding ANNX

# of Institutions
158
Shares Held
102M
Call Options Held
3.61M
Put Options Held
1.08M
View Full List

About Annexon, Inc.

ANNX Quotes by TradingView
  • Ticker ANNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,617,700
  • Market Cap $312M
  • Description
  • Annexon, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutics for autoimmune, neurodegenerative, and ophthalmic disorders. The company's C1q is an initiating molecule of the classical complement pathway that targets distinct disease processes, such as antibody-mediated autoimmune disease and complement-mediated n...
More about ANNX
Track This Portfolio

Track Fairmount Funds Management LLC Portfolio

Follow Fairmount Funds Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fairmount Funds Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fairmount Funds Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email